A cell-based assay for screening lipoxygenase inhibitors

Area of Science:

• Biochemistry
• Enzymology
• Pharmacology

Background:

• Lipoxygenases (LOX) are enzymes involved in lipid peroxidation, with human isoforms playing roles in cellular functions and diseases such as asthma, cardiovascular diseases, and cancer.
• The pharmaceutical industry is actively seeking novel LOX inhibitors due to recent findings linking LOX activity to various pathologies.
• Current high-throughput screening assays for intracellular LOX enzymes are limited, hindering drug discovery efforts.

Purpose of the Study:

• To develop and validate a novel cell-based fluorescence assay for high-throughput screening of lipoxygenase (LOX) inhibitors.
• To provide a reliable and efficient method for identifying potential therapeutic agents targeting LOX enzymes.

Main Methods:

• A cell-based 96-well microplate fluorescence assay was designed to detect LOX activity.
• The assay was tested using several known LOX inhibitors.
• Assay validation was performed by comparing determined IC(50) values with established data and through High-Performance Liquid Chromatography (HPLC) analysis.

Main Results:

• The developed fluorescence assay demonstrated effectiveness in screening existing LOX inhibitors.
• Validation through IC(50) comparisons and HPLC analysis confirmed the assay's reliability.
• The assay provides a viable method for screening novel LOX inhibitors.

Conclusions:

• A novel, validated cell-based fluorescence assay for screening lipoxygenase (LOX) inhibitors has been established.
• This assay offers a valuable tool for the pharmaceutical industry to accelerate the discovery of new LOX-targeting drugs.
• The assay's efficiency and reliability can aid in developing treatments for LOX-related diseases.